Immuno-Biological Laboratories Co. Ltd. (4570.TO) Japan Half-Year Ended September 30 GROUP 2025 2024 Revenue Y485.00 mln Y444.00 mln Operating Profit Y142.00 mln Y68.00 mln Pretax Profit Y149.00 mln ...
Proposed transaction aims to deliver near-term value for ProPhase shareholders, long-term growth for ABL, and create a global, innovation-driven company. Company to hold a virtual conference call ...
Proposed transaction aims to deliver near-term value for ProPhase shareholders, long-term growth for ABL, and create a global, innovation-driven company. Company to hold a virtual conference call ...
St. Luke’s Health Memorial Lufkin is proud to announce the opening of its new, advanced cardiac catheterization laboratory — a major leap forward in cardiovascular care for East Texas. Thanks to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback